Getinge AB ser. B (GETI-B) - Total Assets
Based on the latest financial reports, Getinge AB ser. B (GETI-B) holds total assets worth Skr57.37 Billion SEK (≈ $6.17 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Getinge AB ser. B - Total Assets Trend (2002–2025)
This chart illustrates how Getinge AB ser. B's total assets have evolved over time, based on quarterly financial data. Also see GETI-B stock market capitalisation for the company's overall valuation and market capitalisation.
Getinge AB ser. B - Asset Composition Analysis
Current Asset Composition (December 2025)
Getinge AB ser. B's total assets of Skr57.37 Billion consist of 30.5% current assets and 69.5% non-current assets. Review GETI-B liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr3.40 Billion | 6.0% |
| Accounts Receivable | Skr7.81 Billion | 13.8% |
| Inventory | Skr6.02 Billion | 10.7% |
| Property, Plant & Equipment | Skr4.94 Billion | 8.7% |
| Intangible Assets | Skr7.74 Billion | 13.7% |
| Goodwill | Skr25.77 Billion | 45.6% |
Asset Composition Trend (2002–2025)
This chart illustrates how Getinge AB ser. B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Getinge AB ser. B stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Getinge AB ser. B's current assets represent 30.5% of total assets in 2025, a decrease from 51.2% in 2002.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2025, up from 4.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 29.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 45.6% of total assets.
Getinge AB ser. B Competitors by Total Assets
Key competitors of Getinge AB ser. B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
Getinge AB ser. B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.31 | 1.22 | 5.43 |
| Quick Ratio | 0.74 | 0.70 | 3.63 |
| Cash Ratio | 0.00 | 0.15 | 1.67 |
| Working Capital | Skr3.73 Billion | Skr2.88 Billion | Skr12.37 Billion |
Getinge AB ser. B - Advanced Valuation Insights
This section examines the relationship between Getinge AB ser. B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.11 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -11.6% |
| Total Assets | Skr56.51 Billion |
| Market Capitalization | $6.53 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Getinge AB ser. B's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Getinge AB ser. B's assets decreased by 11.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Getinge AB ser. B (2002–2025)
The table below shows the annual total assets of Getinge AB ser. B from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr56.51 Billion ≈ $6.08 Billion |
-11.60% |
| 2024-12-31 | Skr63.92 Billion ≈ $6.88 Billion |
+19.28% |
| 2023-12-31 | Skr53.59 Billion ≈ $5.77 Billion |
+2.99% |
| 2022-12-31 | Skr52.03 Billion ≈ $5.60 Billion |
+16.78% |
| 2021-12-31 | Skr44.55 Billion ≈ $4.79 Billion |
-1.02% |
| 2020-12-31 | Skr45.01 Billion ≈ $4.84 Billion |
+0.67% |
| 2019-12-31 | Skr44.71 Billion ≈ $4.81 Billion |
+3.14% |
| 2018-12-31 | Skr43.35 Billion ≈ $4.67 Billion |
+2.97% |
| 2017-12-31 | Skr42.10 Billion ≈ $4.53 Billion |
-23.74% |
| 2016-12-31 | Skr55.21 Billion ≈ $5.94 Billion |
+3.71% |
| 2015-12-31 | Skr53.23 Billion ≈ $5.73 Billion |
+0.79% |
| 2014-12-31 | Skr52.82 Billion ≈ $5.68 Billion |
+19.22% |
| 2013-12-31 | Skr44.30 Billion ≈ $4.77 Billion |
+3.22% |
| 2012-12-31 | Skr42.92 Billion ≈ $4.62 Billion |
+3.50% |
| 2011-12-31 | Skr41.47 Billion ≈ $4.46 Billion |
+19.90% |
| 2010-12-31 | Skr34.59 Billion ≈ $3.72 Billion |
-7.77% |
| 2009-12-31 | Skr37.50 Billion ≈ $4.04 Billion |
+13.52% |
| 2008-12-31 | Skr33.03 Billion ≈ $3.55 Billion |
+43.67% |
| 2007-12-31 | Skr22.99 Billion ≈ $2.47 Billion |
+44.81% |
| 2006-12-31 | Skr15.88 Billion ≈ $1.71 Billion |
+9.25% |
| 2005-12-31 | Skr14.53 Billion ≈ $1.56 Billion |
+16.66% |
| 2004-12-31 | Skr12.46 Billion ≈ $1.34 Billion |
+3.53% |
| 2003-12-31 | Skr12.03 Billion ≈ $1.29 Billion |
+26.95% |
| 2002-12-31 | Skr9.48 Billion ≈ $1.02 Billion |
-- |
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more